We are live on ! Find out more
CTKB icon

Cytek Biosciences
CTKB

74 hedge funds and large institutions have $515M invested in Cytek Biosciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 7

267% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 9

42% more funds holding

Funds holding: 52 → 74 (+22)

9.38% more ownership

Funds ownership: 26.2% → 35.59% (+9.4%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less capital invested

Capital invested by funds: $572M → $515M (-$57.2M)

Holders
74
Holders Change
+22
Holders Change %
+42.31%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
33
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$69.4M
2
RCM
RA Capital Management
Massachusetts
+$51M
3
BlackRock
BlackRock
New York
+$50.3M
4
State Street
State Street
Massachusetts
+$14.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$9.7M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$31.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$29M
3
Fidelity International
Fidelity International
Bermuda
-$28.1M
4
MGM
Miura Global Management
New York
-$10.3M
5
OCA
Octagon Capital Advisors
New York
-$6.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
FAM
26
Fred Alger Management
New York
$1.17M -$7.75K -574 -0.5%
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$1.08M +$1.35M +100,000 New
AllianceBernstein
28
AllianceBernstein
Tennessee
$1.06M +$1.33M +98,308 New
Walleye Capital
29
Walleye Capital
New York
$1.05M +$433K +32,032 +49%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$1.04M +$1.1M +81,455 +550%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.02M +$1.28M +95,000 New
Jane Street
32
Jane Street
New York
$837K +$1.05M +77,619 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$765K +$812K +60,125 +555%
TI
34
Trexquant Investment
Connecticut
$599K +$751K +55,596 New
GCM
35
Glenview Capital Management
New York
$597K +$748K +55,413 New
MIM
36
MetLife Investment Management
New Jersey
$590K +$652K +48,305 +749%
Deutsche Bank
37
Deutsche Bank
Germany
$588K +$596K +44,165 +424%
Renaissance Technologies
38
Renaissance Technologies
New York
$585K -$739K -54,700 -50%
JP Morgan Chase
39
JP Morgan Chase
New York
$538K +$540K +39,974 +402%
AIG
40
American International Group
New York
$522K +$539K +39,907 +468%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$450K +$447K +33,090 +381%
Wellington Management Group
42
Wellington Management Group
Massachusetts
$449K +$562K +41,617 New
PP
43
Paloma Partners
Connecticut
$439K +$404K +29,906 +276%
Invesco
44
Invesco
Georgia
$432K +$542K +40,100 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$419K +$385K +28,481 +274%
Wells Fargo
46
Wells Fargo
California
$413K +$175K +12,930 +51%
PPA
47
Parametric Portfolio Associates
Washington
$400K -$549K -40,626 -52%
JF
48
Jump Financial
Illinois
$376K +$471K +34,854 New
EGM
49
Engineers Gate Manager
New York
$354K +$443K +32,799 New
Barclays
50
Barclays
United Kingdom
$351K +$441K +32,656 New
1
2
3 4

CTKB Hedge Fund Activity: Q1 2022 in Review

74 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cytek Biosciences (CTKB) for Q1 2022, worth a combined $515M — down 10% from $572M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CTKB positions and 7 closed out — a net gain of 22 holders — while 33 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $69.4M. The largest seller was OrbiMed, exiting entirely with an estimated $31.4M sold.

  • 74 institutional investors held Cytek Biosciences (CTKB) as of Q1 2022, up from 52 in Q4 2021.
  • Funds reported $515M of Cytek Biosciences stock for Q1 2022, down 10% quarter-over-quarter.
  • 29 funds opened new Cytek Biosciences positions in Q1 2022 and 7 closed out, a net change of +22 holders.
  • The largest Cytek Biosciences buyer in Q1 2022 was Vanguard Group, an estimated $69.4M added.
  • The largest Cytek Biosciences seller in Q1 2022 was OrbiMed, an estimated $31.4M sold.

Based on aggregated 13F filings for Q1 2022.